PAIN THERAPEUTICS WKN: A2PGL8 ISIN: US14817C1071 Kürzel: SAVA Forum: Aktien Thema: Hauptdiskussion

Nicht noch eine Short Sequezee Hoffnung 🙈😬😂 Bin seit Januar bei AMC dabei und kann Short sequezee bald nicht mehr hören 🙈

Danke! Short Squeeze wäre ja schön .... klingt aber etwas theoretisch! Leider finden die meistens einen Ausweg! Obgleich ich mich freuen würde, wenn die ihr fett wegkriegen würden!

Sorry ist auf Englisch. Könnt copy-> Paste in googletranslate machen.

What all this data leads to is an increased risk of the involuntary unwinding of bearish positions. Shorts have to cover at the same time call option writers have to present SAVA shares to deep in-the-money call holders. Both of these events presumably at big losses to the bearish positions. If this, along with longs who see shorts in a vulnerable spot and have a vendetta against them cause a run on demand, then more call options at higher strike prices will land in-the-money. This will force more call option writers to present shares or close their positions at losses. This is what is commonly referred to as a gamma squeeze. It's exactly what the Wallstreetbets retail crowd looks for. Shorts have to hope that SAVA falls under the radar or else they may become the next Melvin Capital to a retail short squeeze.

Between the $85 and $100 strikes, there is a combined open interest of 9,400 call options over the next two Friday expiries. If the stock was to spike over $100, an additional one million of shares would need to be delivered, exasperating any short squeeze that may occur for the bears.

Summary Cassava stock increased 49% last Thursday as a short attack fell on deaf ears in favor of a positive report from the Journal of Neuroscience. The short thesis on simufilam may or may not have merit. The problem is shorts misunderstood market forces and are setting themselves up to be the victims of a squeeze. SAVA stock compares quite favorably to other meme stocks in terms of market cap, short interest and float. Short interest is 30% of the float as of 10/29. The top bonus threshold for management's cash incentive plan is achieved if SAVA holds $119 or more for 20 consecutive business days. Last week's spike in price combined with an active options market leaves SAVA stock as a prime candidate for a gamma squeeze.

Hat jemand Zugang zu Seekingalpha?

https://seekingalpha.com/article/4467802-cassava-sciences-stock-top-contender-short-squeeze

Will die 800,-€ … ob mit oder ohne Elon! Und alles sofort! 🍀🤩

Jepp

Amen 🤣🤣🤣

Jetzt biste erleichtert 🙏

Moin, diese Aktie raubt einem den Nerv. Schon 4x zuckte mein Finger und ich blieb jedesmal drin. Ich hätte meine Anteile so etwas von aufstocken können. Shit, ja hatte jedesmal Angst den Zug zu verpassen. Viel Erfolg und allen. Sorry. Frust musste mal raus.

Bis dahin ist aber noch weiter Weg

Mach ich 😉